Search hospitals > Florida > Hialeah
Panax Clinical Research
Claim this profileHialeah, Florida 33014
Conducts research for Non-alcoholic Fatty Liver Disease
Conducts research for Fatty Liver Disease
Conducts research for Diabetes
Conducts research for Liver Disease
Conducts research for Type 2 Diabetes
42 reported clinical trials
2 medical researchers
Summary
Panax Clinical Research is a medical facility located in Hialeah, Florida. This center is recognized for care of Non-alcoholic Fatty Liver Disease, Fatty Liver Disease, Diabetes, Liver Disease, Type 2 Diabetes and other specialties. Panax Clinical Research is involved with conducting 42 clinical trials across 49 conditions. There are 2 research doctors associated with this hospital, such as Robert Perry and Robert Godfrey Perry.Top PIs
Robert PerryPanax Clinical Research1 year of reported clinical research
Studies Non-alcoholic Fatty Liver Disease
Studies Fatty Liver Disease
8 reported clinical trials
10 drugs studied
Robert Godfrey PerryPanax Clinical Research4 years of reported clinical research
Studies Diabetes
Studies Type 2 Diabetes
3 reported clinical trials
5 drugs studied
Clinical Trials running at Panax Clinical Research
Type 2 Diabetes
Non-alcoholic Fatty Liver Disease
Obesity
Diabetes
Fatty Liver Disease
Liver Disease
High Triglycerides
Chronic Hepatitis D
Osteoarthritis
Chronic Kidney Disease
Orforglipron
for Type 2 Diabetes and Obesity
This trial is testing a new diabetes medication called orforglipron to see if it is safer and more effective than insulin in people with type 2 diabetes who are overweight or obese and at higher risk for heart problems. The study will last several years and involve multiple visits.
Recruiting2 awards Phase 3
BMF-219
for Type 2 Diabetes
This trial tests a new pill called BMF-219 that targets a protein named menin. It includes healthy adults and those with Type 2 Diabetes to see if it helps control blood sugar levels.
Recruiting1 award Phase 1 & 216 criteria
HU6
for Type 2 Diabetes with Risk of Fatty Liver Disease
This is a phase 2 randomized, double-blind, placebo-controlled parallel group study of 3 dose levels of HU6 in obese subjects with type 2 diabetes (T2D) at risk of nonalcoholic steatohepatitis (NASH). Six months (26 weeks) of dosing is planned, and subjects will be followed for safety, efficacy, pharmacodynamics (PD), and pharmacokinetics (PK) during this time. The end-of-study visit will take place approximately 4 weeks after the last dose of the study drug (Week 30).
Recruiting0 awards Phase 27 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Panax Clinical Research?
Panax Clinical Research is a medical facility located in Hialeah, Florida. This center is recognized for care of Non-alcoholic Fatty Liver Disease, Fatty Liver Disease, Diabetes, Liver Disease, Type 2 Diabetes and other specialties. Panax Clinical Research is involved with conducting 42 clinical trials across 49 conditions. There are 2 research doctors associated with this hospital, such as Robert Perry and Robert Godfrey Perry.